Rigour in Governance

We were the first Asian pharma company outside Japan to list on the New York Stock Exchange in 2001. We are committed to the highest standards of compliance, ethics and quality in every activity that we undertake. We are consistently recognised by our stakeholders for our governance. We endeavour to set the bar high and maintain the trust our stakeholders repose in us. We continue to work on progressive and timely disclosures, transparent policies and processes.